CareCloud, Inc. (Nasdaq: CCLD, CCLDP, CCLDO), a leader in
healthcare technology solutions for medical practices and health
systems nationwide, today announced its sponsorship and attendance
at the PrecisionMed Exhibition and Summit 2023. The event is
scheduled to take place from May 23-24, 2023, at the Dubai World
Trade Centre, drawing healthcare professionals from across the
Middle East and North Africa.
As part of its expansion into the Middle East,
CareCloud has achieved a significant milestone by obtaining its
Trade Name Certificate from the United Arab Emirates (UAE) Economic
Department. It officially registers CareCloud's name with the UAE
for its intended business activities, bringing the Company one step
closer to acquiring its trade license, which will enable it to
operate in the UAE. Anticipated to be received in the following
weeks, potentially by June, the trade license represents
CareCloud's commitment to establishing a robust presence in the UAE
and capitalizing on the region's burgeoning healthcare
opportunities.
For more than two decades, CareCloud has
revolutionized the way medical practices operate, making it easier
for physicians and healthcare providers to focus on patient care.
Leveraging the cost-effectiveness of an educated offshore labor
market, CareCloud delivers comprehensive technology-enabled
solutions to healthcare organizations of all sizes, encompassing a
wide range of specialties.
The PrecisionMed Expo provides an exceptional
platform for CareCloud to showcase its latest healthcare technology
solutions and enhance brand exposure across the Gulf Corporation
Council countries. With a reported 81% of visitors actively seeking
new products and 88% expressing interest in meeting suppliers, this
event presents invaluable opportunities for CareCloud to cultivate
partnerships and foster business growth.
Commenting on the significance of participating
in the PrecisionMed Expo 2023, CareCloud President and Chief
Executive Officer Hadi Chaudhry said, "As we pursue emerging growth
opportunities in the Middle East, our participation in this event
is a tremendous opportunity for CareCloud. The imminent plan of the
UAE government to mandate electronic health record adoption
signifies substantial market potential. We have made remarkable
progress in establishing our presence in the country, actively
pursuing certification and planning an exciting groundbreaking
event at the expo.
“With our extensive experience in EHR,
professional services, and technology-enabled revenue cycle
management spanning over two decades, coupled with our reputable
status as a publicly-traded company in the U.S., we are positioned
for success in this region. Furthermore, our cultural familiarity
with the Middle East and our cost-effective operations make us an
attractive partner for this emerging market. We eagerly anticipate
sharing updates on our progress and embracing the meaningful
opportunities that lie ahead."
CareCloud's cutting-edge technology-enabled
revenue cycle management solutions redefine the next generation of
healthcare technology solutions. For further information about
CareCloud and its transformative solutions, please visit
carecloud.com.
About
CareCloudCareCloud (Nasdaq: CCLD, CCLDP, CCLDO)
brings disciplined innovation to the business of healthcare. Our
suite of technology-enabled solutions helps clients increase
financial and operational performance, streamline clinical
workflows and improve the patient experience. More than 40,000
providers count on CareCloud to help them improve patient care
while reducing administrative burdens and operating costs. Learn
more about our products and services, including revenue cycle
management (RCM), practice management (PM), electronic health
records (EHR), business intelligence, patient experience management
(PXM) and digital health, at www.carecloud.com.
Follow CareCloud on LinkedIn, Twitter and Facebook.
Forward-Looking StatementsThis
press release contains various forward-looking statements within
the meaning of the safe harbor provisions of the U.S. Private
Securities Litigation Reform Act of 1995. These statements relate
to anticipated future events, future results of operations or
future financial performance. In some cases, you can identify
forward-looking statements by terminology such as “may,” “might,”
“will,” “shall,” “should,” “could,” “intends,” “expects,” “plans,”
“goals,” “projects,” “anticipates,” “believes,” “seeks,”
“estimates,” “forecasts,” “predicts,” “possible,” “potential,”
“target,” or “continue” or the negative of these terms or other
comparable terminology.
Our operations involve risks and uncertainties,
many of which are outside our control, and any one of which, or a
combination of which, could materially affect our results of
operations and whether the forward-looking statements ultimately
prove to be correct. Forward-looking statements in this press
release include, without limitation, statements reflecting
management's expectations for future financial performance and
operating expenditures, expected growth, profitability and business
outlook, the impact of the Covid-19 pandemic on our financial
performance and business activities, and the expected results from
the integration of our acquisitions.
These forward-looking statements are neither
historical facts nor assurances of future performance. Instead,
they are only predictions, are uncertain and involve substantial
known and unknown risks, uncertainties and other factors which may
cause our (or our industry’s) actual results, levels of activity or
performance to be materially different from any future results,
levels of activity or performance expressed or implied by these
forward-looking statements. New risks and uncertainties emerge from
time to time, and it is not possible for us to predict all of the
risks and uncertainties that could have an impact on the
forward-looking statements, including without limitation, risks and
uncertainties relating to the Company’s ability to manage growth,
migrate newly acquired customers and retain new and existing
customers, maintain cost-effective global operations, increase
operational efficiency and reduce operating costs, predict and
properly adjust to changes in reimbursement and other industry
regulations and trends, retain the services of key personnel,
develop new technologies, upgrade and adapt legacy and acquired
technologies to work with evolving industry standards, compete with
other companies’ products and services competitive with ours, and
other important risks and uncertainties referenced and discussed
under the heading titled “Risk Factors” in the Company’s filings
with the Securities and Exchange Commission. In addition, there is
uncertainty about the spread of the Covid-19 virus and the impact
it may have on the Company’s operations, the demand for the
Company’s services, and economic activity in general.
The statements in this press release are made as
of the date of this press release, even if subsequently made
available by the Company on its website or otherwise. The Company
does not assume any obligations to update the forward-looking
statements provided to reflect events that occur or circumstances
that exist after the date on which they were made.
SOURCE CareCloud
Company Contact:Bill KornChief Strategy
OfficerCareCloudbkorn@carecloud.com
Investor Contact:Asher DewhurstICR
WestwickeCareCloudIR@westwicke.com
Media Inquiries:Alexis FeinbergICR
WestwickeCareCloudPR@westwicke.com
CareCloud (NASDAQ:CCLD)
Historical Stock Chart
From Jun 2024 to Jul 2024
CareCloud (NASDAQ:CCLD)
Historical Stock Chart
From Jul 2023 to Jul 2024